Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids-Experience in a Case Series

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2022-11, Vol.58 (12), p.1732
• Main Authors: Pyra, Krzysztof, Szmygin, Maciej, Szmygin, Hanna, Woźniak, Sławomir, Jargiełło, Tomasz
• Format: Article
• Language: English
• Subjects: Abdominal Pain - etiology; Care and treatment; Complications and side effects; Demographic aspects; Diagnosis; Embolization; Female; Fibroids; Humans; Hysterectomy; Intervention; Intubation; Leiomyoma; Leiomyoma - complications; Leiomyoma - therapy; long-term results; Medical imaging; Ovaries; Patient satisfaction; Prevention; Radiation; Risk factors; Success; Treatment Outcome; unilateral; Uterine artery embolization; Uterine Artery Embolization - adverse effects; Uterine Artery Embolization - methods; Uterine fibroids; Uterine Neoplasms - complications; Uterine Neoplasms - therapy; Veins & arteries
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina58121732

Uterine artery embolization (UAE) has become an accepted and widely performed therapy for patients with symptomatic (reporting at least two of the following symptoms: severe or prolonged menstrual bleeding, abdominal pain, tension in abdomen, problems with urination, constipation or anemia) uterine fibroids. Although in the majority of cases, bilateral occlusion is required to obtain a successful clinical outcome, there are patients in whom treatment of only one uterine artery could be attempted. There are several reasons for unilateral UAE: hemodynamic conditions, technical difficulties, anatomical variants and unilateral dominancy of blood supply to the fibroid. Our aim is to present our 10-year experience with unilateral UAE and evaluate the radiological and clinical outcomes. Records of 369 patients with fibroids who underwent UAE from 2010 to 2021 were analyzed. We identified 26 patients treated with unilateral uterine artery embolization and analyzed the data of these patients. All patients attended medical consultation, were assessed using a five-grade symptom scale and underwent MRI examination. Clinical response was evaluated at least 6 months after the procedure and was categorized to one of the following groups: complete improvement, partial improvement, no change and a worsening in symptoms. Twenty-two patients (85%) reported at least partial improvement 6 months following the procedure. One patient required secondary embolization due to recanalization. The secondary procedure was successful, and complete improvement was achieved. One patient did not observe any clinical improvement, and in two cases, symptom recurrence was observed. All three patients were referred for surgical treatment. No major complications were noted. Overall, the success rate was 88%. The results of our study support the statement that elective unilateral embolization is an appropriate treatment in patients with a dominant uterine artery.